Bibliography to Chapter 1

Mick Mulders

  1. Griffin D.E. Measles Virus, in Fields Virology. Knipe DM , Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE, editors. 4th edition. 2001, Lippincott Williams & Wilkins.
  2. Bankamp B et al. wild-type measles viruses with non-standard genome lengths. PLoS ONE 9, 2014, e95470.
  3. World Health Organization. Genetic diversity of wild-type measles viruses and the global measles nucleotide surveillance database (MeaNS). Weekly Epidemiological Record, 2015, 90, 373-380.
  4. Rota PA et al. Measles. Nature Reviews/ Disease Primers. 2016, 2:16049.
  5. Strebel PM et al. Measles Vaccine, in Vaccines. Plotkin SA, Orenstein WA, Offit PA, editors. Fifth edition. 2008, Saunders Elsevier.
  6. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet, 2003, 361:763-773.
  7. Bellini WJ et al. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized. Journal of Infectious Diseases, 2005, 192:1686-1693.
  8. Miller C et al. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. International Journal of Epidemiology, 1992, 21:998-1006.
  9. Schonberger K et al. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS One, 2013, 8:e68909.
  10. Tipples GA et al. Assessment of immunoglobulin M enzyme immunoassays for diagnosis of measles. Journal of Clinical Microbiology, 2003, 41:4790-4792.
  11. Helfand el al. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. Journal of Medical Virology, 1998, 56:337-341.
  12. Chen et al. Measles antibody: Reevaluation of protective titers. Journal of Infectious Diseases, 1990,162:1036-1042.
  13. Rosen JB et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clinical Infectious Diseases, 2014, 58:1205-1210.
  14. Hahne SJ et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. Journal of Infectious Diseases, 2016, 214:1980-1986.
  15. Rota JS et al. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. Journal of Infectious Diseases, 2011, 204; Suppl 1:S559-563.
  16. Mulders MN et al. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015. Morbidity and Mortality Weekly Report, 2016, 65:438-442.
  17. Durrheim DN et al. Measles - The epidemiology of elimination. Vaccine, 2014, 32:6880-6883.
  18. Fine PEM, Mulholland K. Community Immunity, in Vaccine. Plotkin SA, Orenstein WA, Offit PA, editors. Fifth edition. 2008, Saunders Elsevier.
  19. World Health Organization. Measles vaccines: WHO position paper. Weekly Epidemiological Record, 2009, 84,349-360.
  20. Chantler et al. Rubella Virus, in Fields Virology. Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE, editors. 4th edition. 2001, Lippincott Williams & Wilkins.
  21. Abernathy ES et al. Status of global virologic surveillance for rubella viruses. Journal of Infectious Diseases, 2011, 204; Suppl 1:S524-532.
  22. Bellini WJ, Icenogle JP. Measles and rubella viruses, in Manual of Clinical Microbiology, Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA, editors. 9th edition, 2007, ASM Press.
  23. Centers for Disease Control and Prevention. Rubella, in Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 13th ed. 2015, Washington D.C. Public Health Foundation.
  24. Plotkin SA, Reef SE. Rubella vaccine, in Vaccines. Plotkin SA, Orenstein WA, Offit PA, editors. Fifth edition. 2008, Saunders Elsevier.
  25. World Health Organization. Introducing rubella vaccine into national immunization programmes: a step-by-step guide. 2015.
  26. World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases. 2003.
  27. Vynnycky E et al. Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: A systematic review. PLos One, 2016, 11(3), e0149160.
  28. World Health Organization. Rubella vaccines: WHO position paper. Weekly Epidemiological Record, 2011, 86, 301-316.